Showing results 1 to 20 of 22
next >
| Preview | Issue Date | Title | Author(s) |
| 2014 | A comparison of the predictive accuracy of three screening models (DETECT v.ESC/ERS v. ASIG) for pulmonary arterial hypertension in systemic sclerosis | Hao, Y.J.; Thakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.G.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Hill, C.; Rischmueller, M.; Proudman, S.M.; Nikpour, M.; 3rd Systemic Sclerosis World Congress (6 Feb 2014 - 8 Feb 2014 : Rome, Italy) |
| 2015 | A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis | Hao, Y.; Thakkar, V.; Stevens, W.; Morrisroe, K.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Rischmueller, M.; Proudman, S.M.; Nikpour, M. |
| 2014 | Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Quinlivan, A.; Thakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Hill, C.; Rischmueller, M.; Proudman, S.; Nikpour, M.; 3rd Systemic Sclerosis World Congress (6 Feb 2014 - 8 Feb 2014 : Rome, Italy) |
| 2014 | Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Quinlivan, A.; Thakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Hill, C.; Rischmueller, M.; Proudman, S.; Nikpour, M.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania) |
| 2015 | Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Quinlivan, A.; Thakkar, V.; Stevens, W.; Morrisroe, K.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Rischmueller, M.; Proudman, S.; Nikpour, M. |
| 2012 | Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension | Dalton, B.; McNeil, K.; Keogh, A.; Williams, T.; Proudman, S.; Gabbay, E.; Kotlyar, E.; Weintraub, R.; Kermeen, F.; Celermajer, D.; Boland, J. |
| 2013 | Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease | Moore, O.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Byron, J.; Sahhar, J.; Roddy, J.; Gabbay, E.; Youssef, P.; Nash, P.; Zochling, J.; Proudman, S.; Stevens, W.; Nikpour, M. |
| 2012 | Extent of disease on high-resolution CT lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease | Moore, O.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Byron, J.; Sahhar, J.; Roddy, J.; Gabbay, E.; Youssef, P.; Nash, P.; Zochling, J.; Proudman, S.; Stevens, W.; Nikpour, M.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT) |
| 2016 | Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol | Calderone, A.; Stevens, W.; Prior, D.; Nandurkar, H.; Gabbay, E.; Proudman, S.; Williams, T.; Celermajer, D.; Sahhar, J.; Wong, P.; Thakkar, V.; Dwyer, N.; Wrobel, J.; Chin, W.; Liew, D.; Staples, M.; Buchbinder, R.; Nikpour, M. |
| 2012 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT) |
| 2013 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; Australian Scleroderma Interest Group,; 2012 Annual European Congress of Rheumatology (EULAR) (6 Jun 2012 - 9 Jun 2012 : Berlin, Germany) |
| 2012 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Liew, D.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M. |
| 2012 | Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study | Ngian, G.; Stevens, W.; Prior, D.; Gabbay, E.; Roddy, J.; Tran, A.; Minson, R.; Hill, C.; Chow, K.; Sahhar, J.; Proudman, S.; Nikpour, M. |
| 2003 | Pulmonary arterial hypertension: a new era in management | Keogh, A.; McNeil, K.; Williams, T.; Gabbay, E.; Cleland, L. |
| 2015 | Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease | Moore, O.A.; Proudman, S.M.; Goh, N.; Corte, T.J.; Rouse, H.; Hennessy, O.; Morrisroe, K.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA) |
| 2013 | Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease | Moore, O.; Proudman, S.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Sahhar, J.; Roddy, J.E.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA) |
| 2010 | Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians | Mangat, P.; Conron, M.; Gabbay, E.; Proudman, S.M. |
| 2013 | Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated? | Nikpour, M.; Stevens, W.; Proudman, S.; Buchbinder, R.; Prior, D.; Zochling, J.; Williams, T.; Gabbay, E.; Nandurkar, H. |
| 2014 | The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis | Morrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M. |
| 2011 | The Bosentan Patient Registry: long-term survival in pulmonary arterial hypertension | Keogh, A.; Strange, G.; McNeil, K.; Williams, T.; Gabbay, E.; Proudman, S.; Weintraub, R.; Wlodarczyk, J.; Dalton, B. |
